Dynavax Technologies Corporation
Latest round
- Series D
Last raised
- Apr 2002
Total raised
- $35M
Investors
- 13
About Dynavax Technologies Corporation
Founded in 1996 in Berkeley, US, Dynavax Technologies Corporation is focused on biopharmaceutical advancements, specifically vaccines. The company is currently headquartered in Emeryville, US.A.50 apiece, in an all cash public-to-private transaction. The deal was completed in February 2026, and the company was delisted from Nasdaq Global Select Market. Dynavax Technologies is a commercial-stage biopharmaceutical company concentrating on innovative vaccines that leverage established adjuvant technology. Its flagship product, HEPLISAV-B®, is a novel hepatitis B vaccine designed for enhanced protection and administered in a two-dose regimen. Additionally, CpG 1018®, an adjuvant integral to vaccine development, further emphasizes its commitment to addressing public health needs through improved vaccination solutions. The company serves healthcare providers, government health agencies, and global pharmaceutical partners, primarily in the United States, Europe, and select international markets.Dynavax Technologies Corporation aims to expand its product offerings and market reach. Plans include the ongoing development of additional vaccine candidates, with specific timelines and product details to be determined. New markets will be targeted for expansion, particularly in regions where access to improved immunization solutions is critical.
Who invested in Dynavax Technologies Corporation
13 investors across 1 round
See all investors in Dynavax Technologies Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Apr 25, 2002
Amount
$35M
Investors
Questions about Dynavax Technologies Corporation
Who invested in Dynavax Technologies Corporation?
Dynavax Technologies Corporation has 13 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dynavax Technologies Corporation raised?
Dynavax Technologies Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Dynavax Technologies Corporation last raise money?
Dynavax Technologies Corporation's most recent round on record is a Series D, in Apr 2002.
What does Dynavax Technologies Corporation do?
Founded in 1996 in Berkeley, US, Dynavax Technologies Corporation is focused on biopharmaceutical advancements, specifically vaccines.
Where is Dynavax Technologies Corporation headquartered?
Dynavax Technologies Corporation is headquartered in Emeryville, US.
Which VCs invest in companies like Dynavax Technologies Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Dynavax Technologies Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Dynavax Technologies Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.